Literature DB >> 15297593

Percutaneous pediculoplasty in osteoporotic compression fractures.

Eduardo P Eyheremendy1, Silvina E De Luca, Elisabeth Sanabria.   

Abstract

Percutaneous pediculoplasty is a vertebroplasty-complementary technique that can be carried out with one needle for each single approach. This report describes five cases of osteoporotic vertebral and pedicular compression fractures that were treated with percutaneous vertebroplasty and bilateral pediculoplasty with use of polymethylmethacrylate and high-quality fluoroscopic guidance. All patients reported complete pain relief. This is a safe, fast, and effective treatment for osteoporotic compression fractures with pedicle compromise.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297593     DOI: 10.1097/01.RVI.0000136969.96466.99

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  4 in total

1.  Pediculoplasty combined with vertebroplasty for the treatment of Kummell's disease without neurological impairment: robot-assisted and fluoroscopy-guided.

Authors:  Biao Wang; Yuhang Wang; Qinpeng Zhao; He Zhao; Yongyuan Zhang; Yi Zhan; Liang Yan; Dingjun Hao
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

2.  Percutaneous pediculoplasty for traumatic pedicle fracture. A technical case report.

Authors:  J Singh; M D Baker; P P Morris; C T Whitlow
Journal:  Interv Neuroradiol       Date:  2012-06-04       Impact factor: 1.610

3.  Pedicle involvement on MR imaging is common in osteoporotic compression fractures.

Authors:  M Ishiyama; S Fuwa; Y Numaguchi; N Kobayashi; Y Saida
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

4.  Combined Percutaneous Kyphoplasty/Pediculoplasty by Posterolateral Transpedicular Approach for Painful Cervical Spine Metastases: A Single-Center Prospective Study.

Authors:  Yonghui Xia; Huan Zhai; Xinlei Wang; Yudong Wang; Bo Feng
Journal:  J Pain Res       Date:  2021-06-10       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.